This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
See you next year! September 15 -18, 2025
Hynes Convention CenterBoston, USA

Dr Alla Polozova
Director, Process Development at Amgen
Speaker

Profile

Alla Polozova received her Ph.D. degree in Biophysics from Moscow Institute of Physics and Technology and performed postdoctoral studies in membrane biochemistry, polymer chemistry and lipid metabolism fields at McMaster University (Canada) and National institutes of Health (USA).

Alla is currently a Director, Process Development, at Amgen, Inc., where she is leading a team within Pivotal Attribute Science responsible for analytical development and commercialization of late stage biotherapeutics. Prior to Amgen Alla worked in AstraZeneca / Medimmune and Elan / Liposome company. Throughout her career Alla contributed to development, successful approvals and commercial support of biosimilars, innovative monoclonal antibody therapeutics and vaccines. Alla has a broad expertise in analytical development, contributed to advancement of various analytical techniques ranging from LC-MS to higher order structure methods. Alla current serves as a chair for Biologics CMC Leadership Gorup in IQ Consortium. In the past she served on USP Particular Matter Expert Panel.

Agenda Sessions

  • Developing and Validating Analytical Methods for Biosimilar Analysis

    1:00pm